MannKind | MNKD - Assets

Stock Price
3.60
Daily Change
-1.94 -35.02%
Monthly
-35.49%
Yearly
-34.19%
Q1 Forecast
5.37

MannKind reported $494.64M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Adma Biologics USD 568.69M 10.31M Sep/2025
BioCryst Pharmaceuticals USD 446.42M 10.76M Sep/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Insmed USD 2.26B 96.18M Dec/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
MannKind USD 494.64M 82.94M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Minerva Neurosciences USD 28.09M 2.33M Sep/2025
Novavax USD 1.18B 156.66M Sep/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pfizer USD 208.73B 2.64B Sep/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Xencor USD 875.5M 6.68M Dec/2025